BD FACSDiscover™ S8 Cell Sorter
Closed Special Notice Posted
- Solicitation number
- NIH-NOI-26-PCA-NIDCR-01222
- Agency
-
Office of Logisitics and Acquisition Operations
National Institutes of Health, Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- PSC
- 6640 Laboratory Equipment And Supplies
- Place of performance
- Bethesda, Maryland 20892, United States
Notice details come from SAM.gov. Updated .
About this opportunity
The National Institutes of Health Office of Logistics and Acquisition Operations announced a sole source intent to award Becton, Dickinson and Company / BD Biosciences a firm-fixed-price contract for one BD FACSDiscover S8 Cell Sorter on behalf of the National Institute of Dental and Craniofacial Research, with a June 25, 2026 deadline for submission of capability statements demonstrating equivalent alternatives.
The award is justified under 41 U.S.C. 3304(a)(1) and FAR 6.302-1 based on comprehensive market research comparing products from BD Biosciences, Cytek Biosciences, Sony Biotechnology, Beckman Coulter, and Miltenyi Biotec. NIH determined the BD FACSDiscover S8 is the only commercially available instrument integrating all minimum required capabilities: cell sorting for high-parameter applications, spectral flow cytometry, real-time integrated imaging during acquisition and sorting, analysis and sorting by fluorescence/spectral signatures and morphology, rare-cell sorting, index sorting, and plate sorting in a biosafety-compliant configuration suitable for human cell sorting.
The acquisition covers 16 contract line items including the sorter unit, sheath fluid, calibration beads, consumables, cooling system, biosafety cabinet, air compressor, software, extended warranty, and shipping. Anticipated delivery is 60 to 90 days after award. Prior NIH procurement history with BD totals $1,611,460.67 across two previous awards.
Interested sources may submit capability statements by June 25, 2026 at 11:00 a.m. EST to Linda Smith (linda.smith2@nih.gov) or Danielle Tines (danielle.tines@nih.gov). The Government retains discretion to proceed with sole source award or pursue competitive procurement based on responses received.
Notice text
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
Office of Logistics and Acquisition Operations (OLAO)
For:
National Institute of Dental and Craniofacial Research (NIDCR)
Division of Intramural Research (DIR)
Combined Technical Research Core (CTRC)
2. Action Being Announced
This is a notice of intent, and not a request for competitive quotations, proposals, or bids.
The National Institutes of Health (NIH), on behalf of the National Institute of Dental and Craniofacial Research (NIDCR), intends to negotiate and award a firm-fixed-price sole source contract to:
Becton, Dickinson and Company / BD Biosciences
for the acquisition of one (1) BD FACSDiscover™ S8 Cell Sorter, including required configuration, delivery, installation, biosafety-compliant hood, and standard warranty coverage.
Project Number: PCA-NIDCR-01222
Project Title: BD FACSDiscover™ S8 Cell Sorter
3. Statutory Authority
The Government intends to award this requirement on a sole source basis pursuant to:
- 41 U.S.C. 3304(a)(1), as implemented by FAR 6.302-1, Only One Responsible Source and No Other Supplies or Services Will Satisfy Agency Requirements; and
- as applicable to this acquisition, 41 U.S.C. 1901 and FAR 13.501(a)(1)(ii).
This requirement will be processed as an open-market acquisition.
4. Description of Requirement
The National Institute of Dental and Craniofacial Research (NIDCR), Division of Intramural Research (DIR), Combined Technical Research Core (CTRC), requires the acquisition of a highly specialized commercial laboratory instrument to replace aging and end-of-life cell sorting instruments and to provide advanced capabilities necessary to support current and future NIH intramural research.
The required instrument must provide, at a minimum, the following capabilities:
- Cell sorting capability for high-parameter research applications;
- Spectral flow cytometry capability;
- Integrated real-time imaging during acquisition and/or sorting;
- Ability to analyze and sort cells based on fluorescence/spectral signatures, morphology, and image-derived parameters;
- Support for rare-cell sorting;
- Support for index sorting and plate sorting; and
- A biosafety-compliant configuration suitable for sorting human cells in NIH research environments.
The anticipated delivery period is 60 to 90 days after award for delivery, installation, and acceptance. The acquisition includes a one-year warranty following installation and acceptance.
Files
| File | Type | Posted |
|---|---|---|
| BOM.pdf | ||
| BD NOI.pdf |
Similar open opportunities
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity